糖尿病遗传风险评分与百万退伍军人计划中全因痴呆及临床诊断血管性痴呆相关
在百万退伍军人计划中评估2型糖尿病遗传风险评分(GRS与不含APOE变异的GRS-nonAPOE)与全因痴呆、血管性痴呆及阿尔茨海默病的关联,按欧洲、非洲和西班牙裔分层。欧洲裔中GRS与全因痴呆(OR 1.06)和临床诊断血管性痴呆(OR 1.12)相关,但与阿尔茨海默病无关;非洲裔和西班牙裔中GRS与任何痴呆结局均无关。GRS-nonAPOE在欧洲裔中效应增大,非洲裔中与血管性痴呆相关(OR 1.15)。
要点
- 欧洲裔中GRS与全因痴呆(OR 1.06)和临床诊断血管性痴呆(OR 1.12)相关,与阿尔茨海默病无关。
- 非洲裔和西班牙裔中GRS与任何痴呆结局均无关联。
- GRS-nonAPOE在欧洲裔中与全因痴呆(OR 1.08)、血管性痴呆(OR 1.14)和阿尔茨海默病(OR 1.06)相关。
核心结论
- 研究结果提示糖尿病与全因痴呆及临床诊断血管性痴呆可能存在共享遗传发病机制。
研究设计与样本
- 在百万退伍军人计划(MVP)中评估两种2型糖尿病遗传风险评分(GRS和GRS-nonAPOE,后者不含与阿尔茨海默病相关的rs429358变异)与三种临床痴呆诊断分类的关联。
- 分析按欧洲裔、非洲裔和西班牙裔种族/民族分层进行。
主要发现
- 欧洲裔中GRS与全因痴呆相关(OR 1.06,P=1.60e-07),与临床诊断血管性痴呆相关(OR 1.12,P=5.2e-05),与临床诊断阿尔茨海默病无关(OR 1.02,P=0.43)。
- 非洲裔和西班牙裔中GRS与任何痴呆结局均无关联。
- GRS-nonAPOE在欧洲裔中效应量估计增大且P值降低:全因痴呆OR 1.08(P=2.6e-12),血管性痴呆OR 1.14(P=7.2e-07),阿尔茨海默病OR 1.06(P=0.018)。
- 非洲裔中GRS-nonAPOE与临床诊断血管性痴呆的关联具有统计学显著性(OR 1.15,P=0.016)。
- 西班牙裔中无显著发现。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: Diabetes and dementia are diseases of high health care burden worldwide, and studies have shown that diabetes is associated with an increased relative risk of dementia. We set out to examine whether type 2 diabetes-associated genetic variants were associated with dementia and whether they differed by race/ethnicity or clinical dementia diagnosis. RESEARCH DESIGN AND METHODS: We evaluated associations of two type 2 diabetes genetic risk scores (GRS and GRS-nonAPOE: a score without rs429358, a variant associated with Alzheimer disease [AD]) with three classifications of clinical dementia diagnoses in the Million Veteran Program (MVP): all-cause dementia, vascular dementia (VaD), and AD. We conducted our analysis stratified by European (EUR), African (AFR), and Hispanic (HIS) races/ethnicities. RESULTS: In EUR, we found associations of the GRS with all-cause dementia (odds ratio [OR] 1.06, P = 1.60e-07) and clinically diagnosed VaD (OR 1.12, P = 5.2e-05) but not with clinically diagnosed AD (OR 1.02, P = 0.43). The GRS was not associated with any dementia outcome in AFR or HIS. When testing with GRS-nonAPOE, we found that effect size estimates in EUR increased and P values decreased for all-cause dementia (OR 1.08, P = 2.6e-12), for VaD (OR 1.14, P = 7.2e-07), and for AD (OR 1.06, P = 0.018). For AFR, the association of GRS-nonAPOE and clinically diagnosed VaD (OR 1.15, P = 0.016) was statistically significant. There were no significant findings for HIS. CONCLUSIONS: We found evidence suggesting shared genetic pathogenesis of diabetes with all-cause dementia and clinically diagnosed VaD.
引用
- Litkowski EM, Logue MW, Zhang R, et al. A Diabetes Genetic Risk Score Is Associated With All-Cause Dementia and Clinically Diagnosed Vascular Dementia in the Million Veteran Program. Diabetes Care. 2022. PMID: 36041056. doi:10.2337/dc22-0105
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。